<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Attention deficit hyperactivity disorder in adults: Psychotherapy</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Attention deficit hyperactivity disorder in adults: Psychotherapy</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Attention deficit hyperactivity disorder in adults: Psychotherapy</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mary V Solanto, PhD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">David Brent, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Michael Friedman, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Oct 10, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H3660573"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Once thought to be exclusively a disorder of childhood, longitudinal follow-up studies have shown that attention deficit hyperactivity disorder (ADHD) persists into adulthood in approximately 50 percent of cases [<a href="#rid1">1-6</a>], ADHD is associated with significant impairment in adult functioning in occupational, academic, and social spheres.</p><p>This topic reviews psychotherapy for ADHD in adults. The epidemiology, pathogenesis, clinical manifestations, assessment, diagnosis, and treatment decisions in the management of adult ADHD are found elsewhere. Topics related to ADHD in children and adolescents are also found elsewhere.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/1232.html" rel="external">"Attention deficit hyperactivity disorder in adults: Epidemiology, clinical features, assessment, and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/118534.html" rel="external">"Attention deficit hyperactivity disorder in adults: Treatment overview"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/602.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Epidemiology and pathogenesis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/624.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Clinical features and diagnosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/623.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/16927.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Treatment with medications"</a>.)</p><p></p><p class="headingAnchor" id="H3660364"><span class="h1">OVERVIEW OF MANAGEMENT OF ADHD IN ADULTS</span><span class="headingEndMark"> — </span>We typically prefer combined treatment including pharmacologic management and cognitive-behavioral therapy (CBT), rather than either alone, as the first-line treatment for adults with attention deficit hyperactivity disorder (ADHD). However, in all cases, we discuss treatment options with the patient and account for patient preference. For example, if an individual prefers treatment with either modality as monotherapy, we typically agree to begin treatment with their preferred modality and follow the individual closely to decide whether monotherapy with either treatment is sufficient to improve the person’s symptoms and functioning. (See  <a class="medical medical_review" href="/z/d/html/118534.html" rel="external">"Attention deficit hyperactivity disorder in adults: Treatment overview", section on 'Preference for combination medication and CBT'</a>.)</p><p>Medication and CBT are thought to be complementary in their effects. While stimulant medication (<a class="drug drug_general" data-topicid="9638" href="/z/d/drug information/9638.html" rel="external">methylphenidate</a> and <a class="drug drug_general" data-topicid="99959" href="/z/d/drug information/99959.html" rel="external">amphetamine</a>) and to a lesser extent, nonstimulant medication (<a class="drug drug_general" data-topicid="8787" href="/z/d/drug information/8787.html" rel="external">atomoxetine</a>) can reduce the core symptoms of ADHD, they often insufficiently address difficulties in executive self-management with respect to time and organization [<a href="#rid7">7</a>]. Additionally, problems with and social and emotional self-regulation often lead to continued distress and impairment for adults with ADHD [<a href="#rid8">8</a>]. CBT targeting executive dysfunction helps to develop adaptive skills for time management, organization, and planning. Therapy may also target comorbid disorders that may accompany ADHD. </p><p>Our preference is based on trials supporting combination modality as compared to monotherapy with either. Medication clearly augmented the benefit of CBT in one randomized, controlled, adequately powered study [<a href="#rid9">9</a>]. Five studies have assessed the benefits of adding CBT to medication, with four studies reporting positive results [<a href="#rid10">10-13</a>] and one study reporting negative results [<a href="#rid14">14</a>]. These results, taken together, strongly suggest that the combination of medication and CBT is better than either one alone. Combination treatment for ADHD is discussed further elsewhere. (See  <a class="medical medical_review" href="/z/d/html/118534.html" rel="external">"Attention deficit hyperactivity disorder in adults: Treatment overview", section on 'Preference for combination medication and CBT'</a>.)</p><p class="headingAnchor" id="H3861913725"><span class="h1">CBT TARGETING EXECUTIVE DYSFUNCTION</span><span class="headingEndMark"> — </span>In most cases, our preferred psychotherapy for the treatment of attention deficit hyperactivity disorder (ADHD) in adults, is treatment with cognitive-behavioral therapy targeting executive dysfunction (CBT-EF). In contrast to CBT in general (eg, that does not target executive functioning), CBT-EF focuses on organization, prioritizing tasks, and planning rather than irrational cognitions that engender anxiety or depression (eg, overgeneralization, discounting the positive, all-or-none thinking). (See  <a class="medical medical_review" href="/z/d/html/1232.html" rel="external">"Attention deficit hyperactivity disorder in adults: Epidemiology, clinical features, assessment, and diagnosis", section on 'Executive dysfunction'</a> and <a class="local">'Prevalence of executive dysfunction'</a> below and  <a class="medical medical_review" href="/z/d/html/14612.html" rel="external">"Overview of psychotherapies", section on 'Cognitive and behavioral therapies'</a> and <a class="local">'Content'</a> below.)</p><p>In our clinical experience, psychotherapies that focus intensively on one area of dysfunction (eg, executive dysfunction emotional dysregulation or attentional focus) are more likely to bring about meaningful and lasting changes in functioning than psychotherapies that attempt to address a broad array of dysfunctions.</p><p class="headingAnchor" id="H25767637"><span class="h2">Address substance use disorder prior to treatment</span><span class="headingEndMark"> — </span>Our preference is to refer individuals with ADHD and an active substance use disorder for treatment of the substance use disorder prior to referring for psychotherapy for executive dysfunction. Our rationale is that substance use disorder may limit compliance with and response to psychotherapy (see  <a class="medical medical_review" href="/z/d/html/118534.html" rel="external">"Attention deficit hyperactivity disorder in adults: Treatment overview", section on 'Substance use and alcohol use disorder'</a>). Patients concomitantly abusing substances were generally excluded from the trials of CBT for ADHD. In the absence of data, therefore, we rely on our clinical judgment that it is more likely that substance abuse will compromise the effectiveness of the treatment, which requires motivation, focus, and effort.</p><p class="headingAnchor" id="H3772174854"><span class="h2">Administration</span><span class="headingEndMark"> — </span>We generally provide 12 to 15 sessions of CBT targeting executive functioning to impart skills or strategies to compensate for deficits in executive functioning or self-management. Participants complete assignments at home between sessions to help foster generalization of new adaptive behaviors and beliefs to activities of daily life. For example, practicing time estimation for daily life activities, prioritizing and scheduling tasks in a planner for a day or week, and planning longer term projects using a flow chart.</p><p class="headingAnchor" id="H545716690"><span class="h2">Format and availability</span><span class="headingEndMark"> — </span>CBT programs targeting executive functioning were initially developed for individual [<a href="#rid15">15</a>] or group formats [<a href="#rid16">16</a>]; however, the group format can be adapted to the individual format [<a href="#rid16">16</a>]. Our choice between individual or group treatment is guided by consideration and balance of the following:</p><p>Potential advantages of a group format include:</p><p class="bulletIndent1"><span class="glyph">●</span>Mutual support and encouragement</p><p class="bulletIndent1"><span class="glyph">●</span>Reducing of the stigma of an ADHD diagnosis</p><p class="bulletIndent1"><span class="glyph">●</span>Positive modeling </p><p class="bulletIndent1"><span class="glyph">●</span>Vicarious reinforcement of successful strategies</p><p class="bulletIndent1"><span class="glyph">●</span>Cost-effectiveness</p><p></p><p>Contraindications for group treatment:</p><p class="bulletIndent1"><span class="glyph">●</span>Significant anger management problems (which may alienate other group members)</p><p class="bulletIndent1"><span class="glyph">●</span>Active drug or alcohol abuse (which would have priority for treatment)</p><p class="bulletIndent1"><span class="glyph">●</span>Other severe psychopathology (for which another treatment would have priority)</p><p></p><p class="bulletIndent1">The principal advantage of individual therapy is the opportunity to tailor treatment to the individual, for example, by:</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Selecting certain modules for emphasis and omitting others</p><p class="bulletIndent1"><span class="glyph">●</span>Proceeding at a faster or slower pace than the group</p><p class="bulletIndent1"><span class="glyph">●</span>Allowing opportunities to address the patient’s resistance</p><p class="bulletIndent1"><span class="glyph">●</span>Allowing for flexible scheduling and privacy</p><p></p><p>There have been no head-to-head trials comparing the efficacy of individual versus group delivery.</p><p>The availability of CBT-EF focusing on executive dysfunction varies, though is most likely to be available at large academic medical centers. Therapists specializing in CBT may be found in the database of members of the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.abct.org%2F&amp;token=IQxLzDq4doJGUgaZgeIY08MXApfjGoAxGDjKpmMdi9U%3D&amp;TOPIC_ID=82780" target="_blank">Association for Behavioral and Cognitive Therapies</a>. Individual and group psychotherapy rendered by licensed psychiatrists, psychologists, and social workers are typically covered by insurance in the United States.</p><p class="headingAnchor" id="H1716161165"><span class="h2">Content</span><span class="headingEndMark"> — </span>Manualized CBT programs have been developed to guide clinicians in the delivery of these treatments [<a href="#rid15">15-17</a>]. Deficit areas addressed include:</p><p class="bulletIndent1"><span class="glyph">●</span>Difficulty keeping track of tasks and activities</p><p class="bulletIndent1"><span class="glyph">●</span>Procrastination</p><p class="bulletIndent1"><span class="glyph">●</span>Difficulty prioritizing</p><p class="bulletIndent1"><span class="glyph">●</span>Disorganization</p><p class="bulletIndent1"><span class="glyph">●</span>Poor short and long-term planning</p><p></p><p>Therapeutic strategies used in these CBT programs to address these deficits include [<a href="#rid15">15,16</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Training in specific skills:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Systematic use of tools such as a planner, timer, and task list [<a href="#rid15">15,16</a>]</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Breaking down difficult tasks into manageable parts</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prioritizing tasks</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Developing an enhanced awareness of time (eg, how long things take; how much time remains before a deadline), which can be facilitated through activities such as self-timing exercises and daily time-logging</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Setting up and maintaining organizational systems [<a href="#rid16">16</a>] (eg, for filing papers)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Maintaining effort toward long-term goals by increasing salience of long-term rewards [<a href="#rid16">16</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Self-monitoring can be a useful basis for self-reinforcement when gradual improvements are made in applying skills and modifying behavior. Monitoring may draw on checklists or logging of application of new skills.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Self-instruction – The internalization of new mental and behavioral habits is encouraged by the use of adaptive internal speech that cues desired behavior [<a href="#rid16">16</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Cognitive reframing to address cognitive distortions that generate anxiety, perfectionism, demoralization, and depression [<a href="#rid15">15,16</a>].</p><p></p><p class="headingAnchor" id="H2296241421"><span class="h2">Monitoring</span><span class="headingEndMark"> — </span>We use ADHD symptom checklists to monitor symptoms during treatment. Typically, this is done once during the course of the 15-week treatment. Additionally, the checklist lists the problems and corresponding strategies presented and discussed during the treatment and asks the participant to rate the helpfulness of each strategy. This information, compiled across group members, is used to identify the strategies that need more intensive focus or review. We also find it useful to get input from other informants who are familiar with the patient as well as real world collateral information (eg, job performance, grades).</p><p></p><p>We typically use rating scales assessing the severity of symptoms and domains as a supplement to the clinical interview to guide the initial diagnostic assessment. For all individuals we use the Conners’ Adult ADHD Rating Scale.</p><p>For individuals with prominent executive dysfunction we also administer the Barkley Deficits in Executive Function Scale (<a class="graphic graphic_table graphicRef93441" href="/z/d/graphic/93441.html" rel="external">table 1</a>) to identify symptomatic targets for CBT and to monitor their change over time [<a href="#rid18">18</a>]. The scale includes subscales measuring:</p><p class="bulletIndent1"><span class="glyph">●</span>Self-management to time</p><p class="bulletIndent1"><span class="glyph">●</span>Self-organization/problem-solving</p><p class="bulletIndent1"><span class="glyph">●</span>Self-motivation</p><p class="bulletIndent1"><span class="glyph">●</span>Self-restraint</p><p class="bulletIndent1"><span class="glyph">●</span>Self-regulation of emotions</p><p></p><p>Further discussion of rating scales used in the diagnosis and treatment of ADHD in adults can be found elsewhere. (See  <a class="medical medical_review" href="/z/d/html/118534.html" rel="external">"Attention deficit hyperactivity disorder in adults: Treatment overview", section on 'Monitoring for symptomatic improvement'</a> and  <a class="medical medical_review" href="/z/d/html/1232.html" rel="external">"Attention deficit hyperactivity disorder in adults: Epidemiology, clinical features, assessment, and diagnosis", section on 'Rating scales'</a>.)</p><p class="headingAnchor" id="H1011032036"><span class="h2">Adjunctive interventions for marital or family concerns</span><span class="headingEndMark"> — </span>We use other psychotherapeutic interventions in addition to CBT (eg, marital therapy, couples therapy, or family therapy) where symptoms lead to marital or relationship discord. Additionally, we are sure to educate all adults with ADHD about the elevated risk for substance use disorder and encourage them to drink in moderation or abstain. (See  <a class="medical medical_review" href="/z/d/html/14612.html" rel="external">"Overview of psychotherapies", section on 'Couple therapy'</a> and  <a class="medical medical_review" href="/z/d/html/14843.html" rel="external">"Screening for unhealthy use of alcohol and other drugs in primary care"</a>.)</p><p class="headingAnchor" id="H4192770186"><span class="h2">Rationale for our preference</span><span class="headingEndMark"> — </span>We suggest CBT targeting executive dysfunction rather than other forms of psychotherapy. Different forms of psychotherapy have not been directly compared in trials. However, the evidence supporting use of CBT targeting executive dysfunction is more robust than that for other therapies. If CBT targeting executive dysfunction is unavailable, supportive psychotherapy and psychoeducation may help address symptoms.</p><p></p><p class="headingAnchor" id="H4199484890"><span class="h3">Prevalence of executive dysfunction</span><span class="headingEndMark"> — </span>Executive dysfunction is highly prevalent among adults with ADHD and is associated with significant academic and occupational impairment [<a href="#rid18">18-20</a>]. The great majority of adults with ADHD have difficulty in some aspect of everyday executive function, particularly with respect to time management and efficiency. Clinical trials have supported the use of CBT targeting executive functioning for adults with ADHD [<a href="#rid21">21-23</a>].</p><p>In a meta-analysis (eight trials, n = 351) the effectiveness of CBT in reducing symptoms of ADHD was examined [<a href="#rid23">23</a>]. Results of the meta-analysis appear to support CBT as superior to wait list control with a large effect size (standardized mean difference 0.76, 95% CI 0.21-1.31). Additionally in trials that compared CBT with “active control” groups (ie, a condition, such as a support group, to control for the nonspecific therapeutic effects of treatment) CBT was found to be superior with a small to moderate effect size (standardized mean difference 0.43, 95% CI 0.14-0.71).</p><p>With the exception of baseline severity, which appears to be associated with a better response to treatment in one study [<a href="#rid22">22</a>], ADHD symptom (eg, subtype) sociodemographic (eg, age, gender) and clinical characteristics (eg, comorbidity) of the patients receiving CBT do not appear to be associated with patients’ clinical response in limited research to date. The number of home exercises completed by patients was a significant predictor of the benefit that patients received from the program [<a href="#rid22">22</a>].</p><p class="headingAnchor" id="H1438719711"><span class="h3">Prevalence of co-occurring anxiety or depression</span><span class="headingEndMark"> — </span>Other comorbidities (eg, an anxiety disorder or depression) may be secondary to ADHD-related impairment, and unless severe enough to limit benefits of cognitive therapy, we typically do not delay treatment with CBT. CBT, tailored for anxiety or depression, is also a potential treatment for those disorders.</p><p>Limited data and our clinical experience tell us that psychotherapy for ADHD may serve to reduce comorbid symptoms as well as address executive dysfunction. Co-occurring anxiety or depression may appear closely related to dysfunction resulting from ADHD.</p><p>In a meta-analysis including 20 randomized controlled trials of CBT, of which 5 had active controls, and 12 uncontrolled pretest/posttest comparisons, CBT significantly improved anxiety and depression symptoms, as well as quality of life and emotional dysregulation [<a href="#rid24">24</a>]. Furthermore, these changes were predicted by the reduction in ADHD symptoms, suggesting a cause-effect relationship. However, treatment was less effective for depression and anxiety outcomes when compared with active controls than when compared to wait-list controls or treatment as usual, suggesting that remediation of internalizing symptoms is a nonspecific result of therapy.</p><p class="headingAnchor" id="H3629104251"><span class="h1">OTHER INTERVENTIONS</span><span class="headingEndMark"> — </span>Other forms of psychotherapy such as adapted dialectical behavior therapy (DBT) or mindfulness-based cognitive therapy (MBCT) have been developed to address specific symptoms or deficit foci. There is not strong support for any of these other psychosocial approaches (with the possible exception of mindfulness) as beneficial for treatment of attention deficit hyperactivity disorder (ADHD). We do not routinely use these interventions due to limited support; however, we occasionally use mindfulness as a supplemental strategy for treatment of executive dysfunction in ADHD. These are discussed below.</p><p class="headingAnchor" id="H2309810775"><span class="h2">Reasoning &amp; Rehabilitation 2: A CBT program</span><span class="headingEndMark"> — </span>Other cognitive-behavioral therapy (CBT) programs have been developed to address multiple symptomatic or deficit targets of ADHD with multimodal interventions. For example, Reasoning &amp; Rehabilitation 2 (R&amp;R2) seeks to address multiple problem areas including attentional control, memory and planning, problem solving, emotional control, and social skills. In a trial, 95 adults with ADHD, who were treated with medication, were randomly assigned to 15 session R&amp;R2 CBT versus treatment as usual [<a href="#rid10">10</a>], which is described as including pharmacologic and nonpharmacologic treatments. At the end of treatment, patients who received CBT experienced reduced ADHD symptoms (eg, Kiddie-Schedule for Affective Disorders and Schizophrenia [ADHD section], Clinical Global impression scale, Barkley Current symptoms Scale) compared with the group receiving treatment as usual; this difference was maintained at three-month follow-up. The effect size (0.55) was modest for a trial that did not control for the nonspecific effects of psychotherapy.</p><p class="headingAnchor" id="H3660434"><span class="h2">Mindfulness/mindfulness-based cognitive therapy</span><span class="headingEndMark"> — </span>Mindfulness, a purposeful, nonjudgmental attention to the present moment, is developed through meditation and other practices. In the teaching of mindfulness, an individual is guided to become aware of incoming thoughts, feelings, and sensations, to observe and accept them without judgment, and then to disengage from them. Originally inspired by Asian teachings, training in mindfulness has been applied to patient stress, anxiety, pain, and other problems [<a href="#rid25">25</a>]. MBCT combines the clinical application of mindfulness training with elements of cognitive training. Early research showed promise of MBCT as an intervention to improve focus for people with ADHD [<a href="#rid26">26,27</a>]. Results of more recent studies, however, have been mixed with positive findings reported in comparison with treatment as usual [<a href="#rid28">28,29</a>], but not when compared with an active control condition [<a href="#rid30">30,31</a>]. The use of MBCT in the treatment of unipolar depression is discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/14682.html" rel="external">"Unipolar major depression: Treatment with mindfulness-based cognitive therapy", section on 'Theoretical foundation'</a>.)</p><p class="headingAnchor" id="H281384416"><span class="h2">Adapted dialectical behavior therapy</span><span class="headingEndMark"> — </span>DBT, originally developed to treat borderline personality disorder, does not appear to be useful in the treatment of adult ADHD. DBT, as adapted for adult ADHD, [<a href="#rid32">32,33</a>], is administered to groups over 13 weekly sessions in modules that address a broad array of difficulties. These include emotional awareness and regulation; mindfulness, organization; stress management; interpersonal effectiveness; depression; substance use disorders; as well as behavior analysis, which involves identifying antecedents and consequences of problematic behavior and alternate problem-solving strategies. Randomized trials have shown negative findings to date. It may be the case that, although DBT is well-conceptualized as a potential intervention for ADHD, the very multiplicity of topics addressed in the context of only 13 weekly sessions militates against the efficacy of any one target of the intervention, necessitating a longer period of intervention. [<a href="#rid34">34,35</a>]. (See  <a class="medical medical_review" href="/z/d/html/6618.html" rel="external">"Borderline personality disorder: Psychotherapy", section on 'Efficacy of psychotherapy'</a>.)</p><p class="headingAnchor" id="H2335484396"><span class="h2">Neurofeedback</span><span class="headingEndMark"> — </span>Neurofeedback does not appear to be effective in the treatment of adults with ADHD. Neurofeedback involves training to enhance self-regulatory capacity over brain activity patterns (via electroencephalography) and, theoretically, over mental states. (See  <a class="medical medical_review" href="/z/d/html/623.html" rel="external">"Attention deficit hyperactivity disorder in children and adolescents: Overview of treatment and prognosis", section on 'Other alternative therapies'</a>.)</p><p>Several studies of neurofeedback have been conducted with adults with ADHD, with mixed results. Two studies reported no differences in effectiveness vis a vis ADHD symptoms between neurofeedback and a sham neurofeedback condition [<a href="#rid36">36,37</a>]. A third study included no control condition but reported high rates of response, with 70 percent showing improvement of 50 percent in ADHD symptoms and 55 showing remission [<a href="#rid38">38</a>]. Further research is necessary to identify the bases of the differences in outcome among these studies.</p><p class="headingAnchor" id="H383776366"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Overview of management</strong> – We typically prefer combined treatment including pharmacologic management and cognitive-behavioral therapy (CBT), rather than either alone, as the first-line treatment for adults with attention deficit hyperactivity disorder (ADHD). While medication may reduce the core symptoms it often insufficiently addresses difficulties in executive self-management, maladaptive cognitions and behaviors, and social and emotional self-regulation. (See <a class="local">'Overview of management of ADHD in adults'</a> above and <a class="local">'CBT targeting executive dysfunction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CBT targeting executive dysfunction</strong> – We suggest treatment with CBT targeting executive functioning rather than other forms of psychotherapy for most adults with ADHD (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'CBT targeting executive dysfunction'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Address substance use</strong> – Our preference is to refer individuals with ADHD and an active substance use disorder for treatment of the substance use disorder prior to referring for psychotherapy for executive dysfunction. Our rationale is that substance use disorder may limit compliance with and response to psychotherapy. (See <a class="local">'Address substance use disorder prior to treatment'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Administration </strong>– We generally provide 12 to 15 sessions of CBT targeting executive functioning to impart skills or strategies to compensate for deficits in executive functioning or self-management. (See <a class="local">'Administration'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Monitoring </strong>– We use ADHD symptom checklists such as the Barkley Deficits in Executive Function (<a class="graphic graphic_table graphicRef93441" href="/z/d/graphic/93441.html" rel="external">table 1</a>) scale to monitor symptoms before and after treatment. We also find it useful to get input from other informants who are familiar with the patient as well as real world collateral information (eg, job performance, grades). (See <a class="local">'Monitoring'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other psychotherapy or interventions </strong>– Other forms of psychotherapy including Reasoning &amp; Rehabilitation 2, mindfulness-based cognitive therapy, dialectical behavior therapy, and neurofeedback have been developed to address specific symptoms or foci. As limited data support their efficacy, we typically do not use these treatments. (See <a class="local">'Other interventions'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Barkley RA. Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder. J Clin Psychiatry 2002; 63 Suppl 12:10.</a></li><li><a class="nounderline abstract_t">Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry 2004; 45:195.</a></li><li><a class="nounderline abstract_t">Barkley RA, Fischer M, Smallish L, Fletcher K. Young adult outcome of hyperactive children: adaptive functioning in major life activities. J Am Acad Child Adolesc Psychiatry 2006; 45:192.</a></li><li><a class="nounderline abstract_t">Biederman J, Monuteaux MC, Mick E, et al. Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study. Psychol Med 2006; 36:167.</a></li><li><a class="nounderline abstract_t">Mannuzza S, Klein RG, Bessler A, et al. Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 1998; 155:493.</a></li><li class="breakAll">Weiss G, Hechtman L. Hyperactive Children Grown Up: Empirical Findings and Theoretical Considerations, 2nd ed, The Guileford Press, New York 1993.</li><li><a class="nounderline abstract_t">Biederman J, Mick E, Fried R, et al. Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD. Eur Neuropsychopharmacol 2011; 21:508.</a></li><li><a class="nounderline abstract_t">Beheshti A, Chavanon ML, Christiansen H. Emotion dysregulation in adults with attention deficit hyperactivity disorder: a meta-analysis. BMC Psychiatry 2020; 20:120.</a></li><li><a class="nounderline abstract_t">Cherkasova MV, French LR, Syer CA, et al. Efficacy of Cognitive Behavioral Therapy With and Without Medication for Adults With ADHD: A Randomized Clinical Trial. J Atten Disord 2020; 24:889.</a></li><li><a class="nounderline abstract_t">Young S, Khondoker M, Emilsson B, et al. Cognitive-behavioural therapy in medication-treated adults with attention-deficit/hyperactivity disorder and co-morbid psychopathology: a randomized controlled trial using multi-level analysis. Psychol Med 2015; 45:2793.</a></li><li><a class="nounderline abstract_t">Pan MR, Zhang SY, Qiu SW, et al. Efficacy of cognitive behavioural therapy in medicated adults with attention-deficit/hyperactivity disorder in multiple dimensions: a randomised controlled trial. Eur Arch Psychiatry Clin Neurosci 2022; 272:235.</a></li><li><a class="nounderline abstract_t">Wettstein RKRW, Klabbers Y, Romijn E, et al. [Cognitive behavioral therapy in combination with pharmacotherapy for adults with ADHD]. Tijdschr Psychiatr 2021; 63:550.</a></li><li><a class="nounderline abstract_t">Emilsson B, Gudjonsson G, Sigurdsson JF, et al. Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. BMC Psychiatry 2011; 11:116.</a></li><li><a class="nounderline abstract_t">Corbisiero S, Bitto H, Newark P, et al. A Comparison of Cognitive-Behavioral Therapy and Pharmacotherapy vs. Pharmacotherapy Alone in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)-A Randomized Controlled Trial. Front Psychiatry 2018; 9:571.</a></li><li class="breakAll">Safren SA, Sprich S, Perlman C, Otto M. Mastering Your Adult ADHD: A Cognitive-Behavioral Treatment Program (Therapist Workbook), Oxford University Press, New York 2005.</li><li class="breakAll">Solanto MV. Cognitive-Behavioral Therapy for Adult ADHD: Targeting Executive Dysfunction, The Guilford Press, New York 2011.</li><li class="breakAll">Ramsay JR, Rostain AL. Cognitive-Behavioral Therapy for Adult ADHD: An Integrative Psychosocial and Medical Approach, Routledge, New York 2008.</li><li class="breakAll">Barkley, RA. Barkley Deficits in Executive Functioning Scale (BDEFS) for Adults, The Guilford Press, New York 2011.</li><li><a class="nounderline abstract_t">Barkley RA, Fischer M. Predicting impairment in major life activities and occupational functioning in hyperactive children as adults: self-reported executive function (EF) deficits versus EF tests. Dev Neuropsychol 2011; 36:137.</a></li><li><a class="nounderline abstract_t">Barkley RA, Murphy KR. Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests. Arch Clin Neuropsychol 2010; 25:157.</a></li><li><a class="nounderline abstract_t">Safren SA, Sprich S, Mimiaga MJ, et al. Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial. JAMA 2010; 304:875.</a></li><li><a class="nounderline abstract_t">Solanto MV, Marks DJ, Wasserstein J, et al. Efficacy of meta-cognitive therapy for adult ADHD. Am J Psychiatry 2010; 167:958.</a></li><li><a class="nounderline abstract_t">Young Z, Moghaddam N, Tickle A. The Efficacy of Cognitive Behavioral Therapy for Adults With ADHD: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. J Atten Disord 2020; 24:875.</a></li><li><a class="nounderline abstract_t">López-Pinar C, Martínez-Sanchís S, Carbonell-Vayá E, et al. Efficacy of Nonpharmacological Treatments on Comorbid Internalizing Symptoms of Adults With Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review. J Atten Disord 2020; 24:456.</a></li><li class="breakAll">Kabat-Zinn J. Full catastrophe living: how to cope with stress, pain and illness using mindfulness meditation, Piatkus, London 2006.</li><li class="breakAll">Househam A, Solanto M. Mindfulness as an intervention for ADHD. In: The ADHD Report, Guilford Press, 2016.</li><li><a class="nounderline abstract_t">Zylowska L, Ackerman DL, Yang MH, et al. Mindfulness meditation training in adults and adolescents with ADHD: a feasibility study. J Atten Disord 2008; 11:737.</a></li><li><a class="nounderline abstract_t">Janssen L, Kan CC, Carpentier PJ, et al. Mindfulness-based cognitive therapy v. treatment as usual in adults with ADHD: a multicentre, single-blind, randomised controlled trial. Psychol Med 2019; 49:55.</a></li><li><a class="nounderline abstract_t">Mitchell JT, McIntyre EM, English JS, et al. A Pilot Trial of Mindfulness Meditation Training for ADHD in Adulthood: Impact on Core Symptoms, Executive Functioning, and Emotion Dysregulation. J Atten Disord 2017; 21:1105.</a></li><li><a class="nounderline abstract_t">Hoxhaj E, Sadohara C, Borel P, et al. Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial. Eur Arch Psychiatry Clin Neurosci 2018; 268:321.</a></li><li><a class="nounderline abstract_t">Bachmann K, Lam AP, Sörös P, et al. Effects of mindfulness and psychoeducation on working memory in adult ADHD: A randomised, controlled fMRI study. Behav Res Ther 2018; 106:47.</a></li><li><a class="nounderline abstract_t">Hesslinger B, Tebartz van Elst L, Nyberg E, et al. Psychotherapy of attention deficit hyperactivity disorder in adults--a pilot study using a structured skills training program. Eur Arch Psychiatry Clin Neurosci 2002; 252:177.</a></li><li><a class="nounderline abstract_t">Philipsen A, Richter H, Peters J, et al. Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicentre study. J Nerv Ment Dis 2007; 195:1013.</a></li><li><a class="nounderline abstract_t">Hirvikoski T, Waaler E, Alfredsson J, et al. Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial. Behav Res Ther 2011; 49:175.</a></li><li><a class="nounderline abstract_t">Philipsen A, Graf E, Jans T, et al. A randomized controlled multicenter trial on the multimodal treatment of adult attention-deficit hyperactivity disorder: enrollment and characteristics of the study sample. Atten Defic Hyperact Disord 2014; 6:35.</a></li><li><a class="nounderline abstract_t">Schönenberg M, Wiedemann E, Schneidt A, et al. Neurofeedback, sham neurofeedback, and cognitive-behavioural group therapy in adults with attention-deficit hyperactivity disorder: a triple-blind, randomised, controlled trial. Lancet Psychiatry 2017; 4:673.</a></li><li><a class="nounderline abstract_t">Barth B, Mayer-Carius K, Strehl U, et al. A randomized-controlled neurofeedback trial in adult attention-deficit/hyperactivity disorder. Sci Rep 2021; 11:16873.</a></li><li><a class="nounderline abstract_t">Krepel N, Egtberts T, Sack AT, et al. A multicenter effectiveness trial of QEEG-informed neurofeedback in ADHD: Replication and treatment prediction. Neuroimage Clin 2020; 28:102399.</a></li></ol></div><div id="topicVersionRevision">Topic 82780 Version 20.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12562056" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Major life activity and health outcomes associated with attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14982236" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Young adult follow-up of hyperactive children: antisocial activities and drug use.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16429090" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Young adult outcome of hyperactive children: adaptive functioning in major life activities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16420713" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Young adult outcome of attention deficit hyperactivity disorder: a controlled 10-year follow-up study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9545994" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Adult psychiatric status of hyperactive boys grown up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9545994" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Adult psychiatric status of hyperactive boys grown up.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21303732" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32164655" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Emotion dysregulation in adults with attention deficit hyperactivity disorder: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28413900" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Efficacy of Cognitive Behavioral Therapy With and Without Medication for Adults With ADHD: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26022103" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Cognitive-behavioural therapy in medication-treated adults with attention-deficit/hyperactivity disorder and co-morbid psychopathology: a randomized controlled trial using multi-level analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33615398" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Efficacy of cognitive behavioural therapy in medicated adults with attention-deficit/hyperactivity disorder in multiple dimensions: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34523707" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : [Cognitive behavioral therapy in combination with pharmacotherapy for adults with ADHD].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21787431" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30505283" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : A Comparison of Cognitive-Behavioral Therapy and Pharmacotherapy vs. Pharmacotherapy Alone in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)-A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30505283" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : A Comparison of Cognitive-Behavioral Therapy and Pharmacotherapy vs. Pharmacotherapy Alone in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)-A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30505283" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : A Comparison of Cognitive-Behavioral Therapy and Pharmacotherapy vs. Pharmacotherapy Alone in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)-A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30505283" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : A Comparison of Cognitive-Behavioral Therapy and Pharmacotherapy vs. Pharmacotherapy Alone in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)-A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30505283" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : A Comparison of Cognitive-Behavioral Therapy and Pharmacotherapy vs. Pharmacotherapy Alone in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)-A Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21347918" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Predicting impairment in major life activities and occupational functioning in hyperactive children as adults: self-reported executive function (EF) deficits versus EF tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20197297" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Impairment in occupational functioning and adult ADHD: the predictive utility of executive function (EF) ratings versus EF tests.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20736471" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Cognitive behavioral therapy vs relaxation with educational support for medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20231319" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Efficacy of meta-cognitive therapy for adult ADHD.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27554190" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : The Efficacy of Cognitive Behavioral Therapy for Adults With ADHD: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31189374" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Efficacy of Nonpharmacological Treatments on Comorbid Internalizing Symptoms of Adults With Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31189374" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Efficacy of Nonpharmacological Treatments on Comorbid Internalizing Symptoms of Adults With Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31189374" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Efficacy of Nonpharmacological Treatments on Comorbid Internalizing Symptoms of Adults With Attention-Deficit/Hyperactivity Disorder: A Meta-Analytic Review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18025249" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Mindfulness meditation training in adults and adolescents with ADHD: a feasibility study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29486807" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Mindfulness-based cognitive therapy v. treatment as usual in adults with ADHD: a multicentre, single-blind, randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24305060" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : A Pilot Trial of Mindfulness Meditation Training for ADHD in Adulthood: Impact on Core Symptoms, Executive Functioning, and Emotion Dysregulation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29356899" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Mindfulness vs psychoeducation in adult ADHD: a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29758392" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Effects of mindfulness and psychoeducation on working memory in adult ADHD: A randomised, controlled fMRI study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12242579" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Psychotherapy of attention deficit hyperactivity disorder in adults--a pilot study using a structured skills training program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18091195" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Structured group psychotherapy in adults with attention deficit hyperactivity disorder: results of an open multicentre study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21295767" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Reduced ADHD symptoms in adults with ADHD after structured skills training group: results from a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24132867" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : A randomized controlled multicenter trial on the multimodal treatment of adult attention-deficit hyperactivity disorder: enrollment and characteristics of the study sample.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28803030" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Neurofeedback, sham neurofeedback, and cognitive-behavioural group therapy in adults with attention-deficit hyperactivity disorder: a triple-blind, randomised, controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34413344" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : A randomized-controlled neurofeedback trial in adult attention-deficit/hyperactivity disorder.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32891892" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : A multicenter effectiveness trial of QEEG-informed neurofeedback in ADHD: Replication and treatment prediction.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
